Case researchers lead national effort to track benefits of genetic testing in cancer treatment
Ideastream: Stan Gerson, director of the Case Comprehensive Cancer Center, discussed the unwillingness of insurance companies to pay for therapies based on genetic testing, which prevents the patient from seeking potentially life-saving treatments.
